Drug Profile
Pain therapeutic - Charleston Laboratories/Stanford University School of Medicine
Latest Information Update: 06 Apr 2021
Price :
$50
*
At a glance
- Originator Charleston Laboratories; Stanford University School of Medicine
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Pain
Most Recent Events
- 06 Apr 2021 Pain therapeutic is still in phase II trials in Pain in USA (unspecified) (Charleston Laboratories pipeline, April 2021)
- 29 Mar 2019 Phase-II clinical trials in Pain in USA (Unspecifies) before March 2019 (Charleston Laboratories pipeline, March 2019)
- 28 Mar 2019 Preclinical trials in Pain in USA (Unspecified) before March 2019 (Charleston Laboratories pipeline, March 2019)